AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34836235 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of PXN
Number of subjects: 13
Study 34836235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 13
Study 32576447 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 15) - LCI-triggered bronchoalveolar lavage (BAL)
Number of subjects: 29
Study 32576447 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14) - Standard care without LCI-triggered BAL
Number of subjects: 29
Study 34784246 — intervention group
Group type: COMPARATOR
Intervention: Lumbar spine treatment only (LBO group)
Number of subjects: 76
Study 34784246 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spine and hip treatments (LBH group)
Number of subjects: 76
Study 35601869 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation training guidance based on automatic extraction algorithm
Number of subjects: 81
Study 35601869 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 81
Study 34158553 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided Internet-based intervention for gambling problems (8 weeks)
Number of subjects: 150
Study 34158553 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group with access to treatment-as-usual
Number of subjects: 150
Study 32932401 — intervention group
Group type: EXPERIMENTAL
Intervention: E2/P4 (17β-estradiol/progesterone)
Number of subjects: 0
Study 32932401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32740133 — intervention group
Group type: EXPERIMENTAL
Intervention: Preadmission procedure-specific consent document
Number of subjects: 70
Study 32740133 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preadmission procedure-specific consent document)
Number of subjects: 70
Study 32740133 — intervention group
Group type: EXPERIMENTAL
Intervention: Preadmission procedure-specific consent document (subgroup analysis)
Number of subjects: 70
Study 33905794 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial infections (BIs)
Number of subjects: 201
Study 33905794 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 201
Study 35950904 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial photobiomodulation (t‐PBM) with near‐infrared (NIR) light (830 nm; continuous wave; 35.8 cm2 treatment area; 54.8 mW/cm2 irradiance; 65.8 J/cm2 fluence; 20 min/session; 2 W total power; 2.3 kJ total energy per session), delivered to the prefrontal cortex, bilaterally, twice a week for 6 weeks.
Number of subjects: 49
Study 35950904 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (control group).
Number of subjects: 49
Study 35372974 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video (video first condition)
Number of subjects: 1905
Study 35372974 — intervention group
Group type: COMPARATOR
Intervention: Control group (video last condition)
Number of subjects: 1905
Study 35372974 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video effect on nondonors
Number of subjects: 1905
Study 35372974 — intervention group
Group type: EXPERIMENTAL
Intervention: Racial differences in organ donation intent
Number of subjects: 1905
Study 32462198 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision-related quality of life (VRQoL) assessment using the NEI VFQ-25 questionnaire
Number of subjects: 87
Study 32462198 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal assessment after 1.08 (0.78) years with a median of 2 (2) follow-up visits
Number of subjects: 87
Study 32462198 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of VRQoL with visual functional and structural biomarkers
Number of subjects: 87
Study 35817673 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg the night before surgery, 3 mg in the morning, and 3 mg at bedtime until the third day after CABG)
Number of subjects: 100
Study 35817673 — intervention group
Group type: COMPARATOR
Intervention: Control (1 placebo tablet instead of melatonin, administered similarly to the M group)
Number of subjects: 100
Study 35817673 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 100
Study 34366819 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Therapy (RT)
Number of subjects: 51
Study 34366819 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT)
Number of subjects: 51
Study 36371154 — intervention group
Group type: EXPERIMENTAL
Intervention: iCBT+TAU
Number of subjects: 266
Study 36371154 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 266
Study 35984478 — intervention group
Group type: EXPERIMENTAL
Intervention: CGM-guided insulin adjustment
Number of subjects: 185
Study 35984478 — intervention group
Group type: COMPARATOR
Intervention: POC-guided insulin adjustment
Number of subjects: 185
Study 33771956 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-time wear schedule
Number of subjects: 25
Study 33771956 — intervention group
Group type: COMPARATOR
Intervention: Gradually increasing wear schedule
Number of subjects: 25
Study 32950830 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast combined with intranasal mometasone furoate (Group I)
Number of subjects: 100
Study 32950830 — intervention group
Group type: COMPARATOR
Intervention: Intranasal mometasone furoate alone (Group II)
Number of subjects: 100
Study 36148627 — intervention group
Group type: EXPERIMENTAL
Intervention: Milky lotions containing mevalonolactone (MVL)
Number of subjects: 0
Study 36148627 — intervention group
Group type: COMPARATOR
Intervention: Placebo milky lotions
Number of subjects: 0
Study 35901370 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate training in LGBTQ-affirmative cognitive behavioral therapy (CBT) for 11 weeks
Number of subjects: 121
Study 35901370 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 121
Study 33600233 — intervention group
Group type: EXPERIMENTAL
Intervention: SPN-812 (Viloxazine Extended-Release)
Number of subjects: 0
Study 33118872 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with 5 × 5 mm mycelial discs of Epicoccum sorghinum
Number of subjects: 10
Study 33118872 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with sterile PDA disks
Number of subjects: 10
Study 35283098 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvest (EVH)
Number of subjects: 957
Study 35283098 — intervention group
Group type: COMPARATOR
Intervention: Open vein harvest (OVH)
Number of subjects: 957
Study 33318125 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 14
Study 32720085 — intervention group
Group type: EXPERIMENTAL
Intervention: Wider range of losses
Number of subjects: 0
Study 32720085 — intervention group
Group type: EXPERIMENTAL
Intervention: Wider range of gains
Number of subjects: 0
Study 32720085 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher stakes in previous session
Number of subjects: 0
Study 32720085 — intervention group
Group type: EXPERIMENTAL
Intervention: Currency units ('pennies')
Number of subjects: 0
Study 32720085 — intervention group
Group type: EXPERIMENTAL
Intervention: Currency units ('pounds')
Number of subjects: 0
Study 34175127 — intervention group
Group type: EXPERIMENTAL
Intervention: GMZ2/alum
Number of subjects: 1849
Study 34175127 — intervention group
Group type: COMPARATOR
Intervention: Rabies vaccine
Number of subjects: 1849
Study 35060943 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP Diet (LFD)
Number of subjects: 43
Study 35060943 — intervention group
Group type: COMPARATOR
Intervention: Psyllium (6 g/d)
Number of subjects: 43
Study 32827122 — intervention group
Group type: EXPERIMENTAL
Intervention: NHF 20 L/min
Number of subjects: 12
Study 32827122 — intervention group
Group type: EXPERIMENTAL
Intervention: NHF 50 L/min
Number of subjects: 12
Study 32827122 — intervention group
Group type: COMPARATOR
Intervention: Positive Airway Pressure (PAP) therapy
Number of subjects: 12
Study 32827122 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 12
Study 33401975 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel resistance training (weekly session for 10 weeks)
Number of subjects: 20
Study 33401975 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 32362155 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended psychosocial support program (1 face-to-face contact, 6 online guided modules, 1 telephone contact)
Number of subjects: 148
Study 32362155 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 148
Study 35183160 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped Classroom through Near Peer Education (FC through NPE)
Number of subjects: 82
Study 35183160 — intervention group
Group type: COMPARATOR
Intervention: Conventional education method (Control)
Number of subjects: 82
Study 34118065 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified support by clinical pharmacologists/pharmacists for patients and treatment team
Number of subjects: 202
Study 34118065 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced medication reviews performed by clinical pharmacologists/pharmacists
Number of subjects: 202
Study 34118065 — intervention group
Group type: EXPERIMENTAL
Intervention: New oral anticancer drug regimen
Number of subjects: 202
Study 34118065 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-drug or drug-food interactions
Number of subjects: 202
Study 32349070 — intervention group
Group type: COMPARATOR
Intervention: Preoperative angiotensin system inhibitors
Number of subjects: 5864
Study 32349070 — intervention group
Group type: COMPARATOR
Intervention: Postoperative angiotensin system inhibitors
Number of subjects: 5864
Study 32349070 — intervention group
Group type: COMPARATOR
Intervention: Control (no angiotensin system inhibitors preoperatively)
Number of subjects: 5864
Study 32349070 — intervention group
Group type: COMPARATOR
Intervention: Control (no angiotensin system inhibitors postoperatively)
Number of subjects: 5864
Study 34407780 — intervention group
Group type: EXPERIMENTAL
Intervention: FIT screening with a positive test result
Number of subjects: 0
Study 34407780 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported diet, lifestyle, and demographic data collection
Number of subjects: 0
Study 34407780 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal samples for gut microbiome analyses collected before and 2 and 12 months after colonoscopy
Number of subjects: 0
Study 34407780 — intervention group
Group type: EXPERIMENTAL
Intervention: Linking CRCbiome data to national registries
Number of subjects: 0
Study 36145099 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean red meat (Pirenaica breed)
Number of subjects: 47
Study 36145099 — intervention group
Group type: COMPARATOR
Intervention: Lean white meat (chicken)
Number of subjects: 47
Study 33065080 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month dual antiplatelet therapy (DAPT; ticagrelor and aspirin) followed by 23-month ticagrelor monotherapy
Number of subjects: 1651
Study 33065080 — intervention group
Group type: COMPARATOR
Intervention: 12-month DAPT followed by 12-month aspirin monotherapy
Number of subjects: 1651
Study 34528897 — intervention group
Group type: EXPERIMENTAL
Intervention: iGAM app intervention group (photographed gums weekly for 8 weeks)
Number of subjects: 160
Study 34528897 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (photographed gums at recruitment and 8 weeks later)
Number of subjects: 160
Study 34528897 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received the same message regarding oral hygiene after photo submission
Number of subjects: 160
Study 34528897 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent dental visits
Number of subjects: 160
Study 33120766 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-remifentanil
Number of subjects: 69
Study 33120766 — intervention group
Group type: COMPARATOR
Intervention: Propofol-remifentanil
Number of subjects: 69
Study 33120766 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative pain and patient satisfaction
Number of subjects: 69
Study 35241319 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (73% Roux‐en‐Y) prior to THA
Number of subjects: 71
Study 35241319 — intervention group
Group type: COMPARATOR
Intervention: Contemporary bariatric techniques
Number of subjects: 71
Study 33725858 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 306
Study 33725858 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 306
Study 33725858 — intervention group
Group type: COMPARATOR
Intervention: Control (regular routine of PEG)
Number of subjects: 306
Study 35835726 — intervention group
Group type: EXPERIMENTAL
Intervention: iCT‐SAD
Number of subjects: 102
Study 35835726 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐SAD
Number of subjects: 102
Study 35835726 — intervention group
Group type: COMPARATOR
Intervention: WAIT
Number of subjects: 102
Study 32875456 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 24
Study 32875456 — intervention group
Group type: COMPARATOR
Intervention: Usual Activities (Control)
Number of subjects: 24
Study 32945775 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth-based diabetes self-management education through a mobile app and regular individualized feedback from health care professionals
Number of subjects: 66
Study 32945775 — intervention group
Group type: COMPARATOR
Intervention: Previous diabetes management strategies
Number of subjects: 66
Study 34628506 — intervention group
Group type: EXPERIMENTAL
Intervention: Health consequences about the cardiovascular system
Number of subjects: 777
Study 34628506 — intervention group
Group type: EXPERIMENTAL
Intervention: Health consequences about the mouth
Number of subjects: 777
Study 34628506 — intervention group
Group type: EXPERIMENTAL
Intervention: Health consequences about other digestive issues
Number of subjects: 777
Study 34628506 — intervention group
Group type: EXPERIMENTAL
Intervention: Health consequences about the respiratory system
Number of subjects: 777
Study 34628506 — intervention group
Group type: EXPERIMENTAL
Intervention: Health consequences about early death
Number of subjects: 777
Study 34628506 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of the health consequence
Number of subjects: 777
Study 34628506 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of the warning message (number of characters)
Number of subjects: 777
Study 34628506 — intervention group
Group type: COMPARATOR
Intervention: Cancer health consequences
Number of subjects: 777
Study 34628506 — intervention group
Group type: COMPARATOR
Intervention: Plain language health consequences
Number of subjects: 777
Study 34671129 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomisation (MR) and genetic correlation (GC) methods
Number of subjects: 95
Study 32555573 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily with aspirin
Number of subjects: 0
Study 32555573 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study 36438208 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized cancer screening (sending invitation letters to non-adherent women and sending GPs a list of their non-adherent patients)
Number of subjects: 94393
Study 36438208 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard cancer screening (sending invitation letters to non-adherent women)
Number of subjects: 94393
Study 36438208 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no letters sent to women or GPs)
Number of subjects: 94393
Study 34037666 — intervention group
Group type: EXPERIMENTAL
Intervention: WIV04 vaccine (5 µg/dose; n=13,459)
Number of subjects: 40382
Study 34037666 — intervention group
Group type: EXPERIMENTAL
Intervention: HB02 vaccine (4 µg/dose; n=13,465)
Number of subjects: 40382
Study 34037666 — intervention group
Group type: COMPARATOR
Intervention: Alum-only control (n=13,458)
Number of subjects: 40382
Study 34037666 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (WIV04, HB02, alum-only)
Number of subjects: 40382
Study 32533785 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib combined with four cycles of docetaxel or pemetrexed
Number of subjects: 37
Study 32533785 — intervention group
Group type: COMPARATOR
Intervention: Four cycles of docetaxel or pemetrexed
Number of subjects: 37
Study 35241476 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation
Number of subjects: 0
Study 32795597 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial advanced airway management with laryngeal tube or endotracheal intubation
Number of subjects: 3002
Study 35253623 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic training on the treadmill, three times a week, for 12 weeks
Number of subjects: 34
Study 35253623 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 34
Study 34001682 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory diet (rich in fresh vegetables and fruits, low in saturated and unsaturated fats and carbohydrates, low in food additives, sugar, fast foods and processed foods) and vitamin D supplementation, curcumin, and flax seeds.
Number of subjects: 73
Study 32933221 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper lip horizontal line (ULHL) presence in females
Number of subjects: 643
Study 32933221 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients presenting ULHL characteristics
Number of subjects: 643
Study 32933221 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal pattern analysis in patients with ULHL
Number of subjects: 643
Study 35950763 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialogic learning
Number of subjects: 4
Study 35950763 — intervention group
Group type: COMPARATOR
Intervention: Discussion-based learning
Number of subjects: 4
Study 33491839 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 60
Study 33491839 — intervention group
Group type: EXPERIMENTAL
Intervention: Lindeman bur
Number of subjects: 60
Study 33491839 — intervention group
Group type: EXPERIMENTAL
Intervention: Diamond-tipped piezo
Number of subjects: 60
Study 33491839 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 60
Study 33491839 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser surgery
Number of subjects: 60
Study 32321345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide (CTX)
Number of subjects: 94
Study 32321345 — intervention group
Group type: COMPARATOR
Intervention: SLE without DAH
Number of subjects: 94
Study 36183689 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation test
Number of subjects: 37
Study 36183689 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral stance test
Number of subjects: 37
Study 36183689 — intervention group
Group type: COMPARATOR
Intervention: Sensor organization test
Number of subjects: 37
Study 32309974 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing Outreach Program‐Collaboration (HOP‐C) plus treatment as usual
Number of subjects: 65
Study 32309974 — intervention group
Group type: COMPARATOR
Intervention: Transitional case management plus treatment as usual
Number of subjects: 65
Study 34776188 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish massage on quadriceps for 20-30 min per session (12 sessions)
Number of subjects: 30
Study 34776188 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment (Control)
Number of subjects: 30
Study 34776188 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish massage
Number of subjects: 30
Study 33020088 — intervention group
Group type: EXPERIMENTAL
Intervention: AGT-Reha enhanced home-based exercise training
Number of subjects: 84
Study 33020088 — intervention group
Group type: COMPARATOR
Intervention: Medical exercise therapy (MET)
Number of subjects: 84
Study 35106605 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation group (received eight unexpected, overground, nonparetic-side gait-slips followed by two paretic-side slips)
Number of subjects: 49
Study 35106605 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation group (novel paretic-side slips)
Number of subjects: 49
Study 35106605 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation group (compared to control group on the 2nd paretic slip)
Number of subjects: 49
Study 35106605 — intervention group
Group type: COMPARATOR
Intervention: Control group (received two paretic-side slips)
Number of subjects: 49
Study 32401683 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked practice schedule
Number of subjects: 41
Study 32401683 — intervention group
Group type: EXPERIMENTAL
Intervention: Random practice schedule
Number of subjects: 41
Study 32401683 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 41
Study 32401683 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks A, B, and C (both blocked and random practice)
Number of subjects: 41
Study 32736576 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal palpation with verbal instructions about PFM function and body awareness techniques
Number of subjects: 172
Study 32736576 — intervention group
Group type: COMPARATOR
Intervention: Control group (similar protocol without vaginal palpation)
Number of subjects: 172
Study 36055230 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA-guided risk stratification
Number of subjects: 0
Study 36055230 — intervention group
Group type: COMPARATOR
Intervention: Standard adjuvant chemotherapy
Number of subjects: 0
Study 34929392 — intervention group
Group type: COMPARATOR
Intervention: Control diet (23 g/d fiber)
Number of subjects: 26
Study 34929392 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally-fermented sugarcane bagasse (33 g/d fiber)
Number of subjects: 26
Study 34929392 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber combination (sugarcane bagasse with resistant starch, ∼45 g/d fiber)
Number of subjects: 26
Study 34929392 — intervention group
Group type: COMPARATOR
Intervention: Fiber-supplemented diets vs control diet
Number of subjects: 26
Study 33802283 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (CRE) supplementation at 0.3 g·kg−1·d−1 for seven days
Number of subjects: 11
Study 33802283 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA, maltodextrin) for seven days
Number of subjects: 11
Study 33802283 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (CRE) supplementation
Number of subjects: 11